Liying W. Zhao
1838 North Guangzhou Avenue
Guangzhou, 510515, China
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Reflections on surgical management strategies for locally advanced gastric cancer after neoadjuvant immunotherapy
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: August 11, 2026
ASO Author Reflections: Laparoscopy as a Dynamic Window into Occult Peritoneal Metastasis in Gastric Cancer.
Journal: Annals of surgical oncology
Published: June 04, 2026
The Clinical Value of Laparoscopic Exploration in Diagnosing and Dynamically Assessing Occult Peritoneal Metastasis in Gastric Cancer.
Journal: Annals of surgical oncology
Published: March 25, 2026
Clinical response of immunotherapy targeting programmed cell death receptor 1/programmed cell death ligand 1 in advanced signet-ring-cell gastric cancer.
Journal: Future oncology (London, England)
Published: January 05, 2026
Disitamab vedotin plus programmed death-1 inhibitor for pre-treated HER2 overexpressed advanced gastric cancer: a multicentre retrospective real-world study.
Journal: Annals of medicine
Published: October 11, 2025
Conversion surgery after immunotherapy and chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology: A retrospective cohort study.
Journal: Chinese medical journal
Published: September 25, 2025
Chinese consensus on first-line precision therapy for advanced gastric cancer.
Journal: Innovation (Cambridge (Mass.))
Published: September 16, 2025
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial.
Journal: Nature communications
Published: July 18, 2025
Imaging Characteristics and Clinical Outcomes in Gastric Cancer with Brain Metastasis: A Propensity Score-Matched Study.
Journal: Journal of gastrointestinal cancer
Published: July 13, 2025
ASO Author Reflections: From Downstaging to Cure-Conversion Surgery after Trastuzumab-Based Chemo-Immunotherapy for Stage IV HER2-Positive Gastric Cancer.
Journal: Annals of surgical oncology
Published: June 10, 2025
Conversion Surgery After Trastuzumab-Based Chemotherapy and Immunotherapy for Stage IV HER2-Positive Gastric Cancer: A Retrospective Multicenter Cohort Study.
Journal: Annals of surgical oncology
Published: February 24, 2025
Last Updated: 09/26/2026